Know a great AI tool or AI news source? Submit it to AiByts

Pathos AI

1 story

Stories

  • AI drug development startup Pathos AI closes $237M investment

    Pathos AI Inc. today announced that it has raised $237 million in funding at a $3 billion valuation. Pharmaceutical giant Bristol Myers Squibb Co. led the Series E round with participation from several unnamed returning backers.

    SiliconANGLE4 min read

Showing 1 of 1 stories

You're all caught up.

AiByts Weekly Brief

Get the top AI news and tools straight to your inbox every week.

Weekly · AI news

Join 15,000+ AI enthusiasts